Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. D'Amico, R. Whittington, S. Malkowicz, D. Schultz, Kenneth Blank, Gregory Broderick, John Tomaszewski, Andrew Renshaw, Irving Kaplan, C. Beard, A. Wein (2000)Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
(2014)robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review
J. Beebe-Dimmer, S. Freedland (2013)Prognostic Gleason grade grouping : data based on the modified Gleason scoring system
(2017)Association between total testosterone levels and tumor upgrading in low and intermediate risk prostate cancer
J. Epstein, M. Zelefsky, D. Sjoberg, J. Nelson, L. Egevad, C. Magi-Galluzzi, A. Vickers, A. Parwani, V. Reuter, S. Fine, J. Eastham, P. Wiklund, Misop Han, C. Reddy, J. Ciezki, T. Nyberg, E. Klein (2016)A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
European urology, 69 3
N. Suardi, A. Larcher, A. Haese*, V. Ficarra, A. Govorov, N. Buffi, J. Walz, B. Rocco, M. Borghesi, T. Steuber, G. Pini, A. Briganti, A. Mottrie, G. Guazzoni, F. Montorsi, D. Pushkar, H. Poel (2014)Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
European urology, 66 4
K. Weingärtner, A. Ramaswamy, A. Bittinger, E. Gerharz, D. Voge, H. Riedmiller (1996)Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic.
The Journal of urology, 156 6
L. Moris, T. Broeck, L. Tosco, A. Baelen, P. Gontero, R. Karnes, W. Everaerts, M. Albersen, P. Bastian, P. Chłosta, F. Claessens, F. Chun, M. Graefen, C. Gratzke, B. Kneitz, G. Marchioro, R. Salas, B. Tombal, H. Poel, J. Walz, G. Meerleer, A. Bossi, K. Haustermans, F. Montorsi, H. Poppel, M. Spahn, A. Briganti, S. Joniau (2016)Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection
Frontiers in Surgery, 3
A. Briganti, A. Larcher, F. Abdollah, U. Capitanio, A. Gallina, N. Suardi, M. Bianchi, M. Sun, M. Freschi, A. Salonia, P. Karakiewicz, P. Rigatti, F. Montorsi (2012)Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
European urology, 61 3
A. Heidenreich, Z. Varga, R. Knobloch (2002)Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
The Journal of urology, 167 4
B. Yuh, W. Artibani, A. Heidenreich, Simon Kimm, M. Menon, G. Novara, A. Tewari, K. Touijer, T. Wilson, K. Zorn, S. Eggener (2014)The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.
European urology, 65 5
B. Yuh, N. Ruel, Rosa Mejia, C. Wilson, T. Wilson (2012)Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
European urology, 61 5
A. Porcaro, A. Petrozziello, C. Ghimenton, F. Migliorini, T. Sava, Beatrice Caruso, M. Romano, S. Cavalleri, W. Artibani (2013)Associations of Pretreatment Serum Total Testosterone Measurements with Pathology-Detected Gleason Score Cancer
Urologia Internationalis, 93
S. Herrell (2019)Pelvic Lymph Node Dissection
Operative Dictations in Urologic Surgery
T. Stamey, N. Yang, A. Hay, J. McNeal, F. Freiha, E. Redwine (1988)Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
The New England journal of medicine, 317 15
J. Klap, M. Schmid, K. Loughlin (2015)The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.
The Journal of urology, 193 2
(2016)Analysis of clinical factors predicting tumor upgrading to higher Gleason patterns in a contemporary series of patients who have been evaluated according to the modified Gleason score grading system
A. Porcaro, N. Luyk, P. Corsi, M. Sebben, A. Tafuri, I. Tamanini, T. Processali, M. Cerruto, F. Migliorini, M. Brunelli, S. Siracusano, W. Artibani (2017)Bilateral Lymph Node Micrometastases and Seminal Vesicle Invasion Associated with Same Clinical Predictors in Localized Prostate Cancer
Tumori Journal, 103
A. Heidenreich, C. Ohlmann, S. Polyakov (2007)Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
European urology, 52 1
M. Menon, A. Tewari, J. Peabody (2003)Vattikuti Institute prostatectomy: technique.
The Journal of urology, 169 6
A. D'Amico, R. Whittington, S. Malkowicz, D. Schultz, K. Blank, G. Broderick, J. Tomaszewski, A. Renshaw, I. Kaplan, C. Beard, A. Wein (1998)Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
JAMA, 280 11
J. Srigley, P. Humphrey, M. Amin, Sam Chang, L. Egevad, J. Epstein, D. Grignon, J. McKiernan, R. Montironi, A. Renshaw, V. Reuter, T. Wheeler (2009)Protocol for the examination of specimens from patients with carcinoma of the prostate gland.
Archives of pathology & laboratory medicine, 133 10
A. Porcaro, N. Luyk, P. Corsi, M. Sebben, A. Tafuri, T. Processali, Mattia Cerasuolo, D. Mattevi, M. Cerruto, M. Brunelli, S. Siracusano, W. Artibani (2017)Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer
Urologia Internationalis, 99
J. Gil-Vernet (1996)Prostate cancer: anatomical and surgical considerations.
British journal of urology, 78 2
Qi-qi Mao (2010)Anatomic radical retropubic prostatectomy
Practical Journal of Clinical Medicine
L. Kluth, F. Abdollah, E. Xylinas, M. Rieken, H. Fajkovic, C. Seitz, M. Sun, P. Karakiewicz, P. Schramek, M. Herman, A. Becker, J. Hansen, B. Ehdaie, W. Loidl, K. Pummer, R. Lee, Y. Lotan, D. Scherr, D. Seiler, S. Ahyai, F. Chun, M. Graefen, A. Tewari, A. Nonis, A. Bachmann, F. Montorsi, M. Gönen, A. Briganti, S. Shariat (2014)Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment
British Journal of Cancer, 111
(2007)Anatomic extent of pelvic lymphadenectomy in patients undergoing radical prostectomy
L. Miller, A. Partin, D. Chan, D. Bruzek, A. Dobs, J. Epstein, P. Walsh (1998)Influence of radical prostatectomy on serum hormone levels.
The Journal of urology, 160 2
K. Loughlin (2016)The testosterone conundrum: The putative relationship between testosterone levels and prostate cancer.
Urologic oncology, 34 11
G. Ploussard, A. Briganti, A. taille, A. Haese*, A. Heidenreich, M. Menon, T. Sulser, A. Tewari, J. Eastham (2014)Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
European urology, 65 1
P. Capogrosso, E. Ventimiglia, M. Moschini, L. Boeri, E. Farina, N. Finocchio, G. Gandaglia, N. Fossati, A. Briganti, F. Montorsi, A. Salonia (2017)Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine
The Prostate, 77
(2017)intermediate risk prostate cancer
Benjamin Breyer, Kirsten Greene, Marc Dall'Era, Benjamin Davies, Christopher Kane (2008)Pelvic lymphadenectomy in prostate cancer
Prostate Cancer and Prostatic Diseases, 11
C. Huggins, Clarence Hodges (1941)Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.
CA: a cancer journal for clinicians, 22 4
A. Porcaro, N. Luyk, P. Corsi, M. Sebben, A. Tafuri, D. Mattevi, T. Processali, M. Cerruto, M. Brunelli, S. Antoniolli, S. Siracusano, W. Artibani (2017)Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer
Urologia Internationalis, 99
(2014)Pelvic lymph node dissection during robot - assisted radical prostatectomy : efficacy , and complications . A systematic review of the literature
A. Briganti, M. Blute, James Eastham, M. Graefen, A. Heidenreich, J. Karnes, F. Montorsi, U. Studer (2009)Pelvic lymph node dissection in prostate cancer.
European urology, 55 6
Introduction: Prostate cancer (PCa) patients who are classified into the intermediate risk category represent a heterogeneous population needing further preoperative risk assessment. Objectives: To evaluate clinical total testosterone (TT) associations with lymph node invasion (LNI) in intermediate risk PCa. Material and Methods: Between November 2014 and July 2016, intermediate risk PCa was assessed in 154 patients who underwent extended pelvic lymph node dissection if the risk of LNI was higher than 5%. Clinical factors associated with the risk LNI were investigated by the multinomial logistic regression model. Results: The risk of LNI was assessed higher than 5% in 40.9% of cases of whom 15.5% had LNI. In the multivariate model, the risk of LNI was independently increased by prostate specific antigen (OR = 1.185; p = 0.021) and TT (OR = 1.004; p = 0.036). As a result, TT was an independent factor that associated with LNI because it increased the risk of LNI by 4% for each increment unit of TT. Conclusion: Preoperative TT independently increased the risk of LNI in the intermediate risk class of PCa patients elected to radical prostatectomy and extended pelvic lymph node dissection. TT might be a useful preoperative factor for stratifying intermediate risk patients because of the positive association of TT with high grade tumors.
Current Urology – Karger
Published: Jan 1, 2019
Keywords: Prostate cancer; Radical prostatectomy; Testosterone; Pelvic lymph node dissection; Lymph node invasion; Prostate specific antigen
Access the full text.
Sign up today, get DeepDyve free for 14 days.